DASA to absorb Patologia Clínica Dr. Geraldo Lustosa Cabral in group reorganization

• DASA plans to absorb wholly owned unit Patologia Clínica Dr. Geraldo Lustosa Cabral, folding its operations into the parent and dissolving the subsidiary.
• The subsidiary’s net assets were valued at BRL 16.22 million based on a March 31, 2026 balance sheet, with DASA taking interim balance-sheet movements.
• No capital increase is expected at DASA because it already owns 100% of the unit and carries the investment under equity accounting.
• The transaction is dated July 10, 2026, with effectiveness tied to corporate approvals and registration with the local commercial registry.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DASA - Diagnósticos da América SA published the original content used to generate this news brief on July 13, 2026, and is solely responsible for the information contained therein.